Orkambi could help 45% of cystic fibrosis sufferers in Scotlandpublished at 17:11 British Summer Time 12 June 2018
Tory MSP Maurice Corry highlights the devastating effect cystic fibrosis has.
The damage sustained to sufferers' lungs is progressive, meaning the threat of lung disease increases over time, he explains.
There are approximately 900 people in Scotland with cystic fibrosis, with a median age of 21, Mr Corry highlights.
The Tory MSP notes the average life expectancy of someone with cystic fibrosis is just 31.
Orkambi is able to slow the decline of the lungs, he states.
Mr Corry points to estimates from the Cystic Fibrosis Trust that Orkambi could be effective for 45% of Scots with the condition.